Safety netting versus overtreatment in paediatrics: viral infection or incomplete Kawasaki disease?

Jennifer Michelle Charlesworth1, Bernadette Power2, Edina Moylett3

  • 1Department of Medicine, National University of Ireland-Galway, Galway, Ireland.

BMJ Case Reports
|November 11, 2017
PubMed

Insights

Kawasaki disease (KD), a common childhood vasculitis, can present with incomplete symptoms, potentially delaying diagnosis. Early recognition and treatment are crucial for preventing severe paediatric morbidity.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Systemic Vasculitis

Background:

  • Kawasaki disease (KD) is the leading cause of acquired heart disease in children.
  • Early diagnosis and treatment are vital to prevent coronary artery aneurysms and other cardiovascular complications.

Observation:

  • A case presentation of a 4-year-old boy with prolonged fever, oral changes, and hand/foot blistering.
  • Elevated inflammatory markers were noted, prompting further investigation.

Findings:

  • The case highlights the challenges in diagnosing incomplete Kawasaki disease outside specialized centers.
  • Diagnostic criteria and management strategies for both classic and incomplete KD are discussed.

Implications:

  • Increased awareness of incomplete KD is needed to reduce diagnostic delays.
  • Prompt management can mitigate long-term paediatric morbidity associated with Kawasaki disease.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
225
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
357
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
452
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
322